Ketamine or esketamine during C-section anesthesia lowers early postpartum depression symptom scores in trials, hinting at a new prevention approach under study.
|Videos|February 28, 2022
CORAL Study Brings Positive News for Adults With Depression
Author(s)Sagar V. Parikh, MD, FRCPC
Coadministration of zuranolone with a standard antidepressant yields positive outcomes.
Advertisement
Sagar Parikh, MD, FRCPC, shares news about the CORAL Study examining zuranolone treatment in patients with major depressive disorder, which demonstrated a rapid and statistically significant reduction in depressive symptoms at day 3 and over the 2-week treatment period.
To read more about this study, see:
Dr Parikh is a professor of Depression and Clinical Neuroscience, and Psychiatry Sciences, at the University of Michigan.
Advertisement
Related to this article
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Assessing Interventions for Insomnia in Peri- and Postmenopausal Women
2
October 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
3
ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study
4
GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating Disorders
5